|
   
These programs are available by contacting your Apotex
Representative.
Essentials 2008
Hypertension
Drawing on recommendations from the Canadian
Hypertension Education Program, CE Essentials: Hypertension
provides pharmacists with a concise overview of the
diagnosis, management and monitoring of this important
vascular disorder.
Coming Soon...
Osteoporosis CE Essentials: Osteoporosis reviews the diagnosis,
management and monitoring of this under-recognized
condition that affects 1 in 4 women and 1 in 8 men
over the age of 50 years.
Osteoarthritis Osteoarthritis is the most common form of arthritis,
affecting an estimated 1 in 10 Canadians. Using the
latest clinical practice guidelines, CE Essentials:
Osteoarthritis provides pharmacists with an
up-to-date summary of its treatment.
Asthma CE Essential: Asthma gives pharmacists a timely
overview of asthma treatment, based on the
recently-released Canadian clinical practice
guidelines. Highlights include updated asthma
control criteria and considerations in pediatric
patients.
Essentials 2007
Dyslipidemia
CE Essentials: Dyslipidemia provides pharmacists with a
timely update on the management of dyslipidemia, drawing on
recommendations from the 2006 Canadian clinical practice
guidelines. Chronic Obstructive Pulmonary Disease
CE Essentials: COPD provides a concise yet comprehensive
overview of chronic obstructive pulmonary disease, a
debilitating condition that is currently the fourth leading
cause of death in men and the fifth in women.
Schizophrenia
Schizophrenia affects speech, emotions, behaviour and
thought. It is often mistakenly confused with multiple
personality disorder. CE Essentials: Schizophrenia will help
you understand this complex illness, affecting approximately
1% of the world's population.
Essentials 2006
Heart Failure
Drawing on recommendations from the 2006 Canadian
guidelines, CE Essentials: Heart Failure provides an
overview of heart failure management, with emphasis on the
most prominent type, systolic dysfunction heart failure.
Type 1 Diabetes
The ‘ins and outs' of insulin dosing are presented in CE
Essentials: Type 1 Diabetes. Learn more about the role that
pharmacists can play in helping patients (including children
and adolescents) manage this challenging lifelong condition.
Stroke
Primary and secondary prevention of ischemic stroke are
reviewed in CE Essentials: Stroke, including recommendations
for risk factor management. This module also discusses
current evidence regarding the use of antiplatelet therapies
and warfarin in stroke prevention.
Angina
CE Essentials: Angina reviews current guidelines for
managing angina pectoris, with particular emphasis on
chronic stable angina. Topics include acute and chronic
symptom management, prevention of disease progression and
useful monitoring parameters for pharmacists.
|